Fluorescence-based proteasome activity profiling.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-61779-364-6_13PMID 22065226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Profiling proteasome activity in tissue with fluorescent probes.

  2007cited by this paper
• Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway

  2007cited by this paper
• Bortezomib for the Treatment of Mantle Cell Lymphoma

  2007cited by this paper
• A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.

  2006cited by this paper
• Bortezomib: proteasome inhibition as an effective anticancer therapy.

  2006cited by this paper
• Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.

  2006cited by this paper
• Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib

  2005cited by this paper
• A transgenic mouse model of the ubiquitin/proteasome system

  2003cited by this paper
• Imaging 26S proteasome activity and inhibition in living mice

  2003cited by this paper
• Assays for proteasome inhibition.

  2003cited by this paper
• Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

  2003cited by this paper
• Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy.

  2003cited by this paper
• Solid-phase synthesis of peptide vinyl sulfones as potential inhibitors and activity-based probes of cysteine proteases.

  2003cited by this paper
• The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

  2002cited by this paper
• Subtypes of 20S proteasomes from skeletal muscle.

  2001cited by this paper
• The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

  2001cited by this paper
• Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits.

  2001cited by this paper
• Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

  2000cited by this paper
• Proteasome inhibition measurements: clinical application.

  2000cited by this paper
• Different proteasome subtypes in a single tissue exhibit different enzymatic properties.

  2000cited by this paper
• Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes.

  1998cited by this paper
• Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors.

  1997cited by this paper
• Molecular cloning of the mouse proteasome subunits MC14 and MECL‐1: reciprocally regulated tissue expression of interferon‐γ‐modulated proteasome subunits

  1997cited by this paper
• Vinyl sulfones as mechanism-based cysteine protease inhibitors.

  1995cited by this paper
• New efficient total syntheses of derivatives of protoporphyrin-IX bearing deuteriated methyl groups

  1983cited by this paper
• Rapid chromatographic technique for preparative separations with moderate resolution

  1978cited by this paper
• A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes.

  1977cited by this paper

• Next-generation cell lines for profiling different proteasome forms and their implications in cancer

  2025cites this paper
• Functional 20S Proteasomes in Retroviruses: Evidence in Favor

  2024cites this paper
• Macrophage NRF1 promotes mitochondrial protein turnover via the ubiquitin proteasome system to limit mitochondrial stress and inflammation.

  2024cites this paper
• Disrupted Nitric Oxide Homeostasis Impacts Fertility Through Multiple Processes Including Protein Quality Control

  2024cites this paper
• Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells

  2024cites this paper
• The proteomic landscape of synaptic diversity across brain regions and cell types

  2023cites this paper
• The Effect of the Knockout of Major Transsulfuration Genes on the Pattern of Protein Synthesis in D. melanogaster

  2023cites this paper
• The ATP/Mg2+ Balance Affects the Degradation of Short Fluorogenic Substrates by the 20S Proteasome

  2022cites this paper
• Solid‐Phase Synthesis and Application of a Clickable Version of Epoxomicin for Proteasome Activity Analysis

  2022cites this paper
• Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors

  2021cites this paper
• A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes

  2021influential citation
• TDP‐43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann‐Pick C disease

  2021cites this paper
• Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses

  2021cites this paper
• Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia

  2021cites this paper
• Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology

  2020cites this paper
• Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons

  2019cites this paper
• Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction

  2018cites this paper
• Proteasome Activation by Small Molecules.

  2017cites this paper
• Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells

  2017cites this paper
• Activity‐based probes for the multicatalytic proteasome

  2017cites this paper
• Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways

  2016cites this paper
• Chapter 3: An Overview of Direct and Two-Step Activity-Based Proteasome Profiling Strategies

  2016cites this paper
• Mécanismes moléculaires impliqués dans la plasticité neurovasculaire des cellules souches de glioblastome

  2016cites this paper
• The use of activity based protein profiling to study proteasome biology

  2016cites this paper
• Presentation by MHC Class I Molecules Rules for High-Efficiency Spliced Peptide Definition of Proteasomal Peptide Splicing

  2015cites this paper
• Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage

  2015cites this paper
• Functional transfer of the Papaver SI system into self-compatible A. thaliana and investigating the role of the proteasome in the Papaver SI response

  2015cites this paper
• Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules

  2015cites this paper
• Cellular senescence and protein degradation

  2014cites this paper
• Activity-Based Imaging Probes of the Proteasome

  2013cites this paper
• Modulation du système ubiquitine-protéasome (ups)

  2012cites this paper